Cite
'Cancer 2015': A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic
MLA
Ken Doig, et al. “‘Cancer 2015’: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic.” Journal of Personalized Medicine, Oct. 2015. EBSCOhost, https://doi.org/10.3390/jpm5040354.
APA
Ken Doig, Thomas John, Alexander Dobrovic, Stephen B. Fox, John J McNeil, Theresa M. Hayes, David Thomas, Heather Thorne, Paul J. McMurrick, John P Parisot, Paula Lorgelly, Lara Lipton, Mark Lucas, David M. Ashley, Andrew Fellowes, Paul A. James, Brett Doble, & Gary Richardson. (2015). “Cancer 2015”: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic. Journal of Personalized Medicine. https://doi.org/10.3390/jpm5040354
Chicago
Ken Doig, Thomas John, Alexander Dobrovic, Stephen B. Fox, John J McNeil, Theresa M. Hayes, David Thomas, et al. 2015. “‘Cancer 2015’: A Prospective, Population-Based Cancer Cohort—Phase 1: Feasibility of Genomics-Guided Precision Medicine in the Clinic.” Journal of Personalized Medicine, October. doi:10.3390/jpm5040354.